ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

Epstein Alleges Conflict Of Interest Of Former Chairman And Sloan-Kettering Directors

May 15, 1992

MD Anderson Expands Reach Into Florida, Ohio

September 26, 2014

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

September 4, 1992

“Long Overdue” Efforts By States Urged To Help Fund Community, Regional Cancer Control Efforts

August 4, 1978

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

September 3, 1999

Maguire Backs Cancer Program But Insists On New Emphasis for Prevention

January 26, 1979